RESUMEN
Background: Actually, no drugs provide therapeutic benefit to approximately one-third of depressed patients. Depression is predicted to become the first global disease by 2030. So, new therapeutic interventions are imperative.Research design and methods: Venlafaxine-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) were surface functionalized with two ligands against transferrin receptor to enhance access to brain. An in vitro blood-brain barrier model using hCMEC/D3 cell line was developed to evaluate permeability. In vivo biodistribution studies were performed using C57/bl6 mice. Particles were administered intranasal and main organs were analyzed.Results: Particles were obtained as a lyophilized powder easily to re-suspend. Internalization and permeability studies showed the following cell association sequence: TfRp-NPs>Tf-NPs>plain NPs. Permeability studies also showed that encapsulated VLF was not affected by P-gP pump efflux increasing its concentration in the basolateral side after 24 h. In vivo studies showed that 25% of plain NPs reach the brain after 30 min of one intranasal administration while less than 5% of functionalized NPs get the target.Conclusions: Plain NPs showed the highest ability to reach the brain vs. functionalized NPs after 30 min by intranasal administration. We suggest plain NPs probably travel via direct nose-to-brian route whereas functionalized NPs reach the brain by receptor-mediated endocytosis.
Asunto(s)
Antidepresivos , Portadores de Fármacos , Nanopartículas , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Clorhidrato de Venlafaxina , Administración Intranasal , Animales , Antidepresivos/administración & dosificación , Antidepresivos/farmacocinética , Encéfalo/metabolismo , Línea Celular , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/farmacocinética , Femenino , Humanos , Masculino , Ratones Endogámicos C57BL , Nanopartículas/administración & dosificación , Nanopartículas/química , Permeabilidad , Copolímero de Ácido Poliláctico-Ácido Poliglicólico/administración & dosificación , Copolímero de Ácido Poliláctico-Ácido Poliglicólico/farmacocinética , Distribución Tisular , Clorhidrato de Venlafaxina/administración & dosificación , Clorhidrato de Venlafaxina/farmacocinéticaRESUMEN
Alzheimer's disease is an irreversible, complex and progressive neurodegenerative disorder associated with oxidative stress and mitochondrial dysfunction. Exogenous antioxidants can be beneficial for decreasing oxidative stress, as they are able to reward the lack of efficacy of the endogenous defense systems and raise the overall antioxidant response in a pathological condition. Along our overarching project related with the design and development of potent and safe multi-target mitochondriotropic antioxidants, based on dietary antioxidants, novel derivatives were obtained. Overall, mitochondriotropic antioxidants showed remarkable antioxidant and chelating properties, presenting low cytotoxic effects on human differentiated neuronal (SH-SY5Y) and hepatocarcinoma (HepG2) cells and exhibited neuroprotective properties on SH-SY5Y cells against 6-hydroxydopamine (6-OHDA) or hydrogen peroxide (H2O2) oxidative insults. Moreover, compounds 58, 59, 62, 63, 66 and 67 were able to permeate a layer of hCMEC/D3 cells in a time-dependent manner. Mitochondriotropic antioxidant 67 stands out by its remarkable iron chelating and neuroprotective properties toward both H2O2 and 6-OHDA-induced oxidative damage, drug-like properties and BBB permeability.
Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/fisiopatología , Antioxidantes/síntesis química , Enfermedades Mitocondriales/prevención & control , Enfermedad de Alzheimer/patología , Antioxidantes/farmacología , Barrera Hematoencefálica/metabolismo , Línea Celular , Línea Celular Tumoral , Humanos , Peróxido de Hidrógeno/antagonistas & inhibidores , Fármacos Neuroprotectores/síntesis química , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Oxidopamina/antagonistas & inhibidoresRESUMEN
Oral delivery of proteins is still a challenge in the pharmaceutical field. Nanoparticles are among the most promising carrier systems for the oral delivery of proteins by increasing their oral bioavailability. However, most of the existent data regarding nanosystems for oral protein delivery is from in vitro studies, lacking in vivo experiments to evaluate the efficacy of these systems. Herein, a multifunctional composite system, tailored by droplet microfluidics, was used for dual delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 inhibitor (iDPP4) in vivo. Oral delivery of GLP-1 with nano- or micro-systems has been studied before, but the simultaneous nanodelivery of GLP-1 with iDPP4 is a novel strategy presented here. The type 2 diabetes mellitus (T2DM) rat model, induced through the combined administration of streptozotocin and nicotinamide, a non-obese model of T2DM, was used. The combination of both drugs resulted in an increase in the hypoglycemic effects in a sustained, but prolonged manner, where the iDPP4 improved the therapeutic efficacy of GLP-1. Four hours after the oral administration of the system, blood glucose levels were decreased by 44%, and were constant for another 4 h, representing half of the glucose area under the curve when compared to the control. An enhancement of the plasmatic insulin levels was also observed 6 h after the oral administration of the dual-drug composite system and, although no statistically significant differences existed, the amount of pancreatic insulin was also higher. These are promising results for the oral delivery of GLP-1 to be pursued further in a chronic diabetic model study.
Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Inhibidores de la Dipeptidil-Peptidasa IV/administración & dosificación , Inhibidores Enzimáticos/administración & dosificación , Péptido 1 Similar al Glucagón/antagonistas & inhibidores , Hipoglucemiantes/administración & dosificación , Microfluídica , Animales , Glucemia , Diabetes Mellitus Experimental/tratamiento farmacológico , Insulina , Masculino , Ratas , Ratas WistarRESUMEN
CONTEXT: Coffee silverskin (CS), a food by-product of the coffee roasting industry, has been studied as an active ingredient for skin care products due to its high potential of antioxidant activity and low cytotoxicity. Another food waste used as ingredient with promising characteristics is obtained from Medicago sativa (MS), which antioxidants and isoflavones content is high. OBJECTIVE: The aim of this study is to evaluate and characterize a new body formulation containing two food by-products extracts. MATERIALS AND METHODS: Different parameters (such as pH, rheological behavior, color, antioxidant content and microbiological analysis) of a body cream formulation containing by-products (CSMS) and a formulation without extracts (F) were evaluated under a stability study during 180 days at different temperatures. Moreover, the in vitro cell toxicity and the in vivo skin safety and protective effects were also assessed. RESULTS: Formulation showed stable physical properties and antioxidant activity during 180 days of storage. In vitro toxicity was screened in two skin cell lines (fibroblasts and keratinocytes) and any toxicity was reported. The in vivo test carried out showed that, with respect to irritant effects, CSMS formulation can be regarded as safe for topical application and the skin hydratation improved after 30 days of its use. Also, considering the consumer acceptance, more than 90% of volunteers classified it as very pleasant. CONCLUSIONS: CSMS formulation is stable and safe for topical use as no adverse and/or side effects were observed during the application period of testing, improving skin protective properties.
Asunto(s)
Antioxidantes/administración & dosificación , Antioxidantes/química , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Crema para la Piel/administración & dosificación , Crema para la Piel/química , Piel/metabolismo , Administración Tópica , Adulto , Línea Celular , Química Farmacéutica/métodos , Café/química , Cosméticos/administración & dosificación , Cosméticos/química , Estabilidad de Medicamentos , Femenino , Alimentos , Humanos , Masculino , Medicago sativa/química , Persona de Mediana EdadRESUMEN
Daptomycin may offer an antibacterial alternative for the treatment of endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA) and other potential agents. In the present project, mucoadhesive chitosan-coated alginate (CS-ALG) nanoparticles are proposed as an effective delivery system for daptomycin permeation across ocular epithelia, with potential for the treatment of bacterial endophthalmitis. CS-ALG nanoparticles were prepared by ionotropic pre-gelation of an alginate core followed by chitosan polyelectrolyte complexation, and characterized regarding particle size, polydispersity, and zeta potential. The encapsulation efficiency was determined and antimicrobial activity was also tested after encapsulation of the antibiotic. Also, in vitro ocular permeability of free daptomycin and encapsulation into chitosan and CS-ALG nanoparticles was evaluated using ocular epithelial cell culture models. Formulated daptomycin-loaded CS-ALG nanoparticles were negatively charged, with a size range of 380-420 nm, suitable for ocular application. The encapsulation efficiency was between 79 and 92 %, with decreasing alginate:daptomycin mass ratios. The antibacterial activity of daptomycin against major microorganisms responsible for bacterial endophthalmitis was not affected by encapsulation into nanoparticles. Daptomycin permeability was up to 16 % (chitosan nanoparticles) and 9 % (CS-ALG nanoparticles) through corneal cell monolayer, and 18 % (chitosan nanoparticles) and 12 % (CS-ALG nanoparticles) for retinal cell monolayer after 4 h, demonstrating epithelial retention of the drug compared to free drug. The developed daptomycin-loaded CS-ALG nanoparticles seem to be an interesting and potential system for ocular daptomycin delivery and treatment of bacterial endophthalmitis.
Asunto(s)
Antibacterianos/farmacología , Daptomicina/farmacología , Portadores de Fármacos/metabolismo , Nanopartículas/metabolismo , Alginatos/metabolismo , Antibacterianos/metabolismo , Infecciones Bacterianas/tratamiento farmacológico , Línea Celular , Quitosano/metabolismo , Daptomicina/metabolismo , Portadores de Fármacos/síntesis química , Endoftalmitis/tratamiento farmacológico , Ácido Glucurónico/metabolismo , Ácidos Hexurónicos/metabolismo , Humanos , Pruebas de Sensibilidad MicrobianaRESUMEN
Consumers nowadays are playing an active role in their health-care. A special case is the increasing number of women, who are reluctant to use exogenous hormone therapy for the treatment of menopausal symptoms and are looking for complementary therapies. However, food supplements are not clearly regulated in Europe. The EFSA has only recently begun to address the issues of botanical safety and purity regulation, leading to a variability of content, standardization, dosage, and purity of available products. In this study, isoflavones (puerarin, daidzin, genistin, daidzein, glycitein, genistein, formononetin, prunetin, and biochanin A) from food supplements (n = 15) for menopausal symptoms relief are evaluated and compared with the labelled information. Only four supplements complied with the recommendations made by the EC on the tolerable thresholds. The intestinal bioavailability of these compounds was investigated using Caco-2 cells. The apparent permeability coefficients of the selected isoflavonoids across the Caco-2 cells were affected by the isoflavone concentration and product matrix.
Asunto(s)
Suplementos Dietéticos/análisis , Enterocitos/metabolismo , Absorción Intestinal , Isoflavonas/análisis , Fitoestrógenos/análisis , Absorción Fisiológica , Australia , Células CACO-2 , Permeabilidad de la Membrana Celular , Suplementos Dietéticos/economía , Suplementos Dietéticos/normas , Unión Europea , Femenino , Aditivos Alimentarios/efectos adversos , Aditivos Alimentarios/análisis , Aditivos Alimentarios/química , Inspección de Alimentos , Etiquetado de Alimentos , Guías como Asunto , Humanos , Isoflavonas/química , Isoflavonas/metabolismo , Estructura Molecular , Concentración Osmolar , Fitoestrógenos/química , Fitoestrógenos/metabolismo , Fitoestrógenos/normas , Posmenopausia , Autocuidado , Estados UnidosRESUMEN
Numerous studies in humans, animal models and cell lines have suggested the potential benefits from the consumption of green tea polyphenols, including prevention of cancer and heart diseases. However these potential effects have been strongly limited by green tea catechins low bioavailability, which hinders the development of therapeutic applications. In this review formulations that are being proposed for delivery of green tea catechins are discussed. New delivery systems are presented as valid alternatives to overcome the limitations such as green tea catechins poor stability or intestinal absorption.
Asunto(s)
Catequina/química , Catequina/metabolismo , Portadores de Fármacos/química , Té/química , Animales , Disponibilidad Biológica , Catequina/análogos & derivados , Catequina/farmacocinética , Emulsiones/química , Humanos , Liposomas/química , Nanopartículas/química , Polímeros/química , Té/metabolismoRESUMEN
Public space is endowed with undeniable social relevance, thus becoming a defining element of integration and interaction among its users. Aware of this importance the Universidade Federal da Paraíba (UFPB), linked to the Ministério da Educação e Cultura (MEC), develops the project "UFPB para todos: eliminando barreiras'' (UFPB for all: removing barriers) that aims to conceive an architectural design of an accessible rout to UFPB's campus I, and execute a pilot stretch of this route. This article aims to subsidize the preprojectual phase by understanding the needs of this campus' users, through the concepts of ergonomics and universal design. Was performed out direct observation of the space, and the methods of interviews and observation of user behavior were applied to a group of students with disabilities, through the techniques of assisted walking, photographic and video recording. Based on those, projective guidelines have been defined, which will contribute to the final project's quality, so that this is not a simple application of the rule, but works free of segregating barriers.
Asunto(s)
Accesibilidad Arquitectónica , Personas con Discapacidad , Planificación Ambiental , Ergonomía , Universidades , Brasil , Planificación de Ciudades , Humanos , Entrevistas como Asunto , Evaluación de Necesidades , ObservaciónRESUMEN
Chitosan, a natural biopolymer presents antifungal activity that seems to be dependent on the interaction of its cationic amino groups and yeast cell surface. In this work we used ion-exchange chromatography to assess the surface charge density of Candida species and subsequently to relate this with their sensitivity profile to chitosan. The ability of several strains from distinct Candida species to interact with strong anionic and cationic exchangers was tested and the yeasts charge surface was assessed by measuring the zeta potential. Our results showed that all the yeast cells tested presented no interaction with the cationic resin and a species-related pattern of interaction was observed with the anionic resin. Specifically, regarding the Q-Sepharose support, Candida glabrata showed the lower retention affinity, followed by Candida albicans, presenting Candida tropicalis an intermediate profile; Candida parapsilosis and Candida guilliermondii revealed a stronger ionic interaction. The yeasts retention synergy in the anionic resin corroborates with the zeta potential outcomes. The behavior observed fit with sensitivity patterns to chitosan as the most susceptible species to chitosan presented higher affinity to the anionic resin in contrast to the less sensitive ones (C. albicans and C. glabrata). This data confirms and reinforces that chitosan activity is probably mediated by an ionic reaction between its amino free groups and ionic charges at the cell surface.
Asunto(s)
Candida/química , Quitosano/farmacología , Cromatografía por Intercambio Iónico/métodos , Antifúngicos/farmacología , Candida/citología , Candida/efectos de los fármacos , Fenómenos Electromagnéticos , Resinas de Intercambio Iónico , Sefarosa , Especificidad de la EspecieRESUMEN
Alginate nanoparticles were prepared from dilute alginate sol by inducing a pre-gel with calcium counter ions, followed by polyelectrolyte complex coating with chitosan. Particles in the nanometer size range were obtained with 0.05% alginate and 0.9 mM Ca2+. The mean particle size was influenced by time and stirring speed of nanoparticle preparation, by alginate guluronic acid content and chitosan molecular weight and by the initial alginate:chitosan mass ratio. The association efficiency of insulin into alginate nanoparticles, as well as loading capacity were mainly influenced by the alginate:chitosan mass ratio. Under optimized size conditions, the association efficiency and loading capacities were as high as 92% and 14.3%, respectively. Approximately 50% of the protein was partially retained by the nanoparticles in gastric pH environment up to 24 hours while a more extensive release close to 75% was observed under intestinal pH conditions. Mild formulation conditions, optimum particle size range obtained, high insulin entrapment efficiency, and resistance to gastrointestinal release seem to be synergic and promising factors toward development of an oral insulin delivery form.
Asunto(s)
Alginatos/química , Quitosano/química , Electrólitos/química , Insulina/metabolismo , Nanocompuestos/química , Nanopartículas/química , Acetatos/química , Calcio/química , Cloruro de Calcio/química , Sistemas de Liberación de Medicamentos , Geles , Concentración de Iones de Hidrógeno , Insulina/química , Iones , Microscopía Electrónica de Rastreo , Tamaño de la Partícula , Polímeros/químicaRESUMEN
PURPOSE: To evaluate the pharmacological activity of insulin-loaded alginate/chitosan nanoparticles following oral dosage in diabetic rats. METHODS: Nanoparticles were prepared by ionotropic pre-gelation of an alginate core followed by chitosan polyelectrolyte complexation. In vivo activity was evaluated by measuring the decrease in blood glucose concentrations in streptozotocin induced, diabetic rats after oral administration and flourescein (FITC)-labelled insulin tracked by confocal microscopy. RESULTS: Nanoparticles were negatively charged and had a mean size of 750 nm, suitable for uptake within the gastrointestinal tract due to their nanosize range and mucoadhesive properties. The insulin association efficiency was over 70% and insulin was released in a pH-dependent manner under simulated gastrointestinal conditions. Orally delivered nanoparticles lowered basal serum glucose levels by more than 40% with 50 and 100 IU/kg doses sustaining hypoglycemia for over 18 h. Pharmacological availability was 6.8 and 3.4% for the 50 and 100 IU/kg doses respectively, a significant increase over 1.6%, determined for oral insulin alone in solution and over other related studies at the same dose levels. Confocal microscopic examinations of FITC-labelled insulin nanoparticles showed clear adhesion to rat intestinal epithelium, and internalization of insulin within the intestinal mucosa. CONCLUSION: The results indicate that the encapsulation of insulin into mucoadhesive nanoparticles was a key factor in the improvement of its oral absorption and oral bioactivity.
Asunto(s)
Alginatos/química , Glucemia/efectos de los fármacos , Quitosano/química , Diabetes Mellitus Experimental/tratamiento farmacológico , Portadores de Fármacos , Hipoglucemiantes/farmacología , Insulina/farmacología , Nanopartículas , Administración Oral , Animales , Disponibilidad Biológica , Química Farmacéutica , Diabetes Mellitus Experimental/sangre , Relación Dosis-Respuesta a Droga , Composición de Medicamentos , Fluoresceína-5-Isotiocianato/análogos & derivados , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Concentración de Iones de Hidrógeno , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/química , Hipoglucemiantes/farmacocinética , Insulina/administración & dosificación , Insulina/análogos & derivados , Insulina/química , Insulina/farmacocinética , Absorción Intestinal , Mucosa Intestinal/metabolismo , Masculino , Microscopía Confocal , Tamaño de la Partícula , Ratas , Ratas Wistar , SolubilidadRESUMEN
The aim of the present study was to probe the structural integrity of insulin after being entrapped into chitosan/alginate nanoparticles produced by ionotropic polyelectrolyte pre-gelation. By manipulating the alginate:chitosan mass ratio and the pH during nanoparticle production, desired nanoparticles with a mean size of 850 (+/-88)nm and insulin association efficiency of 81 (+/-2)% were obtained. Insulin secondary structure was assessed by Fourier transform infrared (FTIR) and circular dichroism (CD) after entrapment into nanoparticles and after release from the particles under gastrointestinal simulated conditions. FTIR second-derivative spectra and area-overlap compared to an insulin standard confirmed that no significant conformational changes of insulin occurred in terms of alpha-helix and beta-sheet content. Far-UV-CD spectra corroborated the preservation of insulin structure during the nanoparticle production procedure. The presented nanoparticulate system is a promising carrier for insulin oral delivery since it preserves insulin structure and therefore also, potentially, its bioactivity.